| 28.06 17:49 | Aktien Schweiz gehen knapp behauptet in Wochenende |
| 28.06 14:14 | dpa-AFX: Roche's PiaSky Gets Positive Recommendation From CHMP For Treatment Of PNH |
| 28.06 13:52 | dpa-AFX: Roche: Vabysmo Gets CHMP Recommendation For Third Indication |
| 28.06 13:42 | dpa-AFX: *CHMP RECOMMENDS ROCHE'S VABYSMO FOR THIRD INDICATION RETINAL VEIN OCCLUSION |
| 28.06 13:36 | dpa-AFX: Roche-Medikamente Piasky und Vabysmo erhalten positive Empfehlungen |
| 28.06 13:31 | dpa-AFX: *ROCHE: VABYSMO ERHÄLT CHMP-EMPFEHLUNG FÜR DIE DRITTE INDIKATION |
| 28.06 13:15 | Press Release: Roche's Vabysmo gets CHMP -3- |
| 28.06 13:15 | Press Release: Roche's Vabysmo gets CHMP recommendation for third indication retinal vein occlusion (RVO) |
| 28.06 13:15 | Press Release: Roche's Vabysmo gets CHMP -2- |
| 28.06 13:07 | dpa-AFX: *ROCHE: CHMP RECOMMENDS EU APPROVAL OF PIASKY FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA |
| 28.06 13:00 | Press Release: CHMP recommends EU approval of Roche's PiaSky for people with PNH, a rare, life-threatening blood condition |
| 28.06 13:00 | Press Release: CHMP recommends EU approval of -2- |
| 27.06 17:51 | Aktien Schweiz mit leichten Abgaben |
| 27.06 07:20 | dpa-AFX: Roche Gets WHO Prequalification For Cobas HPV Test On Multiple Systems, Incl. Self-Collected Samples |
| 27.06 07:04 | dpa-AFX: *ROCHE EXPANDS ACCESS TO CERVICAL CANCER SCREENING TOOLS WITH TWO NEW WHO PREQUALIFICATION DESIGNATIONS |
| 27.06 07:00 | Press Release: Roche expands access to cervical cancer screening tools with two new WHO prequalification designations, including HPV self-collection |
| 27.06 07:00 | Press Release: Roche expands access to cervical -2- |
| 26.06 17:48 | Aktien Schweiz erneut mit Abschlägen |
| 25.06 17:48 | Aktien Schweiz nach deutlichem Vortagesplus mit Abgaben |
| 25.06 07:48 | dpa-AFX: Roche's Ocrevus Subcutaneous Injection For Multiple Sclerosis Gets Approval In EU |
|
|
